Eficacia y seguridad de rituximab en neuropatía vasculítica: revisión sistemática

Aldea, 2012, [Monoclonal antibodies in inflammatory disease of the muscle and peripheral nervous system], Neurologia., 27, 39 Jennette, 2013, 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides, Arthritis Rheum., 65, 1, 10.1002/art.37715 Muñoz, 2012, Vasculitis del nervio periférico: revisión clinico-patológica de 13 casos, Rev Chil Reumatol., 28, 82 Tavee, 2017, Immune axonal polyneuropathy, Continuum (Minneap Minn)., 23, 1394 Mathew, 2007, Treatment of vasculitic peripheral neuropathy: A retrospective analysis of outcome, QJM., 100, 41, 10.1093/qjmed/hcl125 Pagnoux, 2005, Peripheral neuropathy in systemic vasculitides, Curr Opin Rheumatol., 17, 41, 10.1097/01.bor.0000145518.91595.2f Suppiah, 2011, Rheumatology (Oxford)., 50, 2214, 10.1093/rheumatology/ker266 Garcia-Bragado, 1988, Peripheral neuropathy in essential mixed cryoglobulinemia, Arch Neurol., 45, 1210, 10.1001/archneur.1988.00520350048015 Gemignani, 2002, Cryoglobulinemia is a frequent cause of peripheral neuropathy in undiagnosed referral patients, J Peripher Nerv Syst., 7, 59, 10.1046/j.1529-8027.2002.02007.x Saleh, 2005, Classification and diagnostic criteria in systemic vasculitis, Best Pract Res Clin Rheumatol., 19, 209, 10.1016/j.berh.2004.09.001 Collins, 2004, Non-systemic vasculitic neuropathy, Curr Opin Neurol., 17, 587, 10.1097/00019052-200410000-00009 Hernandez-Rodriguez, 2008, Single-organ vasculitis, Curr Opin Rheumatol., 20, 40, 10.1097/BOR.0b013e3282f176a0 Gwathmey, 2014, Vasculitic neuropathies, Lancet Neurol., 13, 67, 10.1016/S1474-4422(13)70236-9 Benstead, 2014, Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection, Cochrane Database Syst Rev., Cd010404 Pietrogrande, 2011, Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients, Autoimmun Rev., 10, 444, 10.1016/j.autrev.2011.01.008 MabThera, European Medicines Agency. 2018. Disponible en: https://www.ema.europa.eu/medicines/human/EPAR/mabthera Cavallo, 2009, Rituximab in cryoglobulinemic peripheral neuropathy, J Neurol., 256, 1076, 10.1007/s00415-009-5072-z Novikov, 2016, Rituximab as induction therapy in relapsing eosinophilic granulomatosis with polyangiitis: A report of 6 cases, Joint Bone Spine., 83, 81, 10.1016/j.jbspin.2015.04.016 Ferri, 2011, Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: Results of multicenter cohort study and review of the literature, Autoimmun Rev., 11, 48, 10.1016/j.autrev.2011.07.005 De Vita, 2012, A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis, Arthritis Rheum., 64, 843, 10.1002/art.34331 Quartuccio, 2015, Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study, J Autoimmun., 63, 88, 10.1016/j.jaut.2015.07.012 Jones, 2010, Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis, N Engl J Med., 363, 211, 10.1056/NEJMoa0909169 Stone, 2010, Rituximab versus cyclophosphamide for ANCA-associated vasculitis, N Engl J Med., 363, 221, 10.1056/NEJMoa0909905 Guillevin, 2014, Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis, N Engl J Med., 371, 1771, 10.1056/NEJMoa1404231 Roccatello, 2007, Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis, Am J Kidney Dis., 49, 69, 10.1053/j.ajkd.2006.09.015 Misiani, 1992, Hepatitis C virus infection in patients with essential mixed cryoglobulinemia, Ann Intern Med., 117, 573, 10.7326/0003-4819-117-7-573 Dammacco, 2013, Therapy for hepatitis C virus-related cryoglobulinemic vasculitis, N Engl J Med., 369, 1035, 10.1056/NEJMra1208642 Sandri, 2011, Treatment of hepatitis C-mediated glomerular disease, Nephron Clin Pract., 119, c121, 10.1159/000325220 McGregor, 2015, Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis, Nephrol Dial Transplant., 30 Suppl1, i123, 10.1093/ndt/gfv076